https://www.selleckchem.com/products/sh-4-54.html
The secondary outcome measure was PJI incidence. We identified 631 primary TKAs in 556 patients, of which 331 received IORA. The mean age was 67.7 ± 8.7 years, and 57.8% were women. CKD was prevalent in 17.2% of the cohort. AKI occurred in 25 (3.9%) cases. After controlling for covariates, CKD was the only significant predictor of AKI (odds ratio= 3.035, P= .023). RMS and neutropenia were not observed in this cohort. The 90-day PJI rate was 0%, and the 1-year PJI rate was 0.2%. Low-dose IORA of vancomycin in addition to standard intrave
Like
Comment
Share
